Figure 3: Immunohistochemistry (IHC) and Immunofluorescence (IF) analysis of MD2 expression and immune cell infiltration in prostate cancer tissues. (Upper panel) Representative IF images showing ...
Impact of androgen receptor pathway inhibitor (ARPI) dose reduction on overall survival of metastatic castration-resistant prostate cancer: A multi-centre retrospective study.
President Joe Biden recently gave an update on his treatment for metastatic prostate cancer. A urologist explains ways to ...
New findings out of VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM)—published in Pharmacological Research, ranked among the top pharmacology journals globally ...
Bone metastases represent a common and debilitating stage in the progression of many solid tumours, notably breast, prostate and lung cancers. Tumour cells that home to the skeleton disrupt the normal ...
In this long-term follow-up to the phase 2 ARTO trial, researchers analyzed survival outcomes in patients with CRPC treated with metastasis-directed therapy.
Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 Study The classification of patients with prostate cancer, based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results